Loading...
CE Holdings Co., Ltd.
4320.T•JPX
Healthcare
Medical - Healthcare Information Services
¥698.00
¥-1.00(-0.14%)
CE Holdings Co., Ltd. (4320.T) Financial Performance & Income Statement Overview
Review CE Holdings Co., Ltd.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
6.76%
↑ 6.76%
Operating Income Growth
-8.50%
↓ 8.50%
Net Income Growth
-82.05%
↓ 82.05%
Operating Cash Flow Growth
-5.47%
↓ 5.47%
Operating Margin
10.45%
↑ 10.45%
Gross Margin
24.006%
↑ 24.006%
Net Profit Margin
2.92%
↑ 2.92%
ROE
7.38%
↑ 7.38%
ROIC
18.32%
↑ 18.32%
CE Holdings Co., Ltd. (4320.T) Income Statement & Financial Overview
Review CE Holdings Co., Ltd.'s (4320.T) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $3.80B | $3.64B | $2.85B | $4.90B |
| Cost of Revenue | $2.88B | $2.67B | $2.33B | $3.80B |
| Gross Profit | $913.00M | $971.00M | $515.67M | $1.10B |
| Gross Profit Ratio | $0.24 | $0.27 | $0.18 | $0.22 |
| R&D Expenses | $0.00 | $15.00M | $0.00 | $2.00M |
| SG&A Expenses | $523.00M | $390.00M | $549.42M | $539.47M |
| Operating Expenses | $523.00M | $530.00M | $547.84M | $541.47M |
| Total Costs & Expenses | $3.41B | $3.19B | $2.88B | $4.35B |
| Interest Income | $0.00 | $0.00 | $4000.00 | $15000.00 |
| Interest Expense | $0.00 | $0.00 | $3.60M | $3.73M |
| Depreciation & Amortization | $173.00M | $173.00M | $336.17M | $123.09M |
| EBITDA | $563.00M | $614.00M | -$120.75M | $678.44M |
| EBITDA Ratio | $0.15 | $0.17 | -$0.04 | $0.14 |
| Operating Income | $390.00M | $441.00M | -$32.17M | $554.26M |
| Operating Income Ratio | $0.10 | $0.12 | -$0.01 | $0.11 |
| Other Income/Expenses (Net) | -$11.00M | -$7.00M | -$428.35M | -$2.65M |
| Income Before Tax | $379.00M | $434.00M | -$460.52M | $551.62M |
| Income Before Tax Ratio | $0.10 | $0.12 | -$0.16 | $0.11 |
| Income Tax Expense | $149.00M | $105.00M | $83.03M | $193.31M |
| Net Income | $200.00M | $291.00M | -$539.73M | $326.65M |
| Net Income Ratio | $0.05 | $0.08 | -$0.19 | $0.07 |
| EPS | $13.23 | $19.25 | -$35.93 | $21.68 |
| Diluted EPS | $13.23 | $19.25 | -$35.93 | $21.68 |
| Weighted Avg Shares Outstanding | $15.12M | $15.12M | $15.02M | $15.07M |
| Weighted Avg Shares Outstanding (Diluted) | $15.12M | $15.12M | $15.02M | $15.07M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan